Fidelity Investments’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$278M Buy
8,884,363
+596,864
+7% +$18.7M 0.02% 692
2025
Q1
$278M Buy
8,287,499
+762,209
+10% +$25.6M 0.02% 673
2024
Q4
$295M Buy
7,525,290
+607,606
+9% +$23.8M 0.02% 664
2024
Q3
$272M Buy
6,917,684
+149,511
+2% +$5.89M 0.02% 702
2024
Q2
$264M Buy
6,768,173
+166,343
+3% +$6.49M 0.02% 687
2024
Q1
$284M Buy
6,601,830
+945,908
+17% +$40.7M 0.02% 646
2023
Q4
$261M Buy
5,655,922
+1,403,056
+33% +$64.6M 0.02% 647
2023
Q3
$145M Sell
4,252,866
-935,841
-18% -$32M 0.01% 823
2023
Q2
$200M Buy
5,188,707
+460,858
+10% +$17.7M 0.02% 718
2023
Q1
$169M Buy
4,727,849
+37,020
+0.8% +$1.32M 0.02% 773
2022
Q4
$185M Buy
4,690,829
+21,070
+0.5% +$831K 0.02% 714
2022
Q3
$169M Buy
4,669,759
+97,391
+2% +$3.52M 0.02% 744
2022
Q2
$139M Buy
4,572,368
+738,892
+19% +$22.5M 0.01% 831
2022
Q1
$117M Sell
3,833,476
-76,541
-2% -$2.34M 0.01% 1008
2021
Q4
$122M Buy
3,910,017
+853,261
+28% +$26.7M 0.01% 1017
2021
Q3
$46.7M Sell
3,056,756
-15,688
-0.5% -$240K ﹤0.01% 1439
2021
Q2
$57.2M Sell
3,072,444
-14,800
-0.5% -$276K ﹤0.01% 1369
2021
Q1
$55.3M Buy
3,087,244
+461,692
+18% +$8.26M ﹤0.01% 1350
2020
Q4
$40.4M Buy
2,625,552
+932
+0% +$14.3K ﹤0.01% 1404
2020
Q3
$29.1M Buy
2,624,620
+425,566
+19% +$4.71M ﹤0.01% 1414
2020
Q2
$27.6M Buy
2,199,054
+611,518
+39% +$7.67M ﹤0.01% 1424
2020
Q1
$18M Buy
+1,587,536
New +$18M ﹤0.01% 1448
2016
Q1
Sell
-910,920
Closed -$7.32M 2748
2015
Q4
$7.32M Hold
910,920
﹤0.01% 2089
2015
Q3
$7.52M Sell
910,920
-230,142
-20% -$1.9M ﹤0.01% 2048
2015
Q2
$13.2M Sell
1,141,062
-115,177
-9% -$1.33M ﹤0.01% 1910
2015
Q1
$21.2M Hold
1,256,239
﹤0.01% 1711
2014
Q4
$24.8M Buy
+1,256,239
New +$24.8M ﹤0.01% 1644